Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $298.97M.
ENTERPRISE VALUE (EV)
$298.97M
Eikon Therapeutics, Inc. Common Stock
Market Cap
$403.87M
Enterprise Value (EV)
$298.97M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $403.87M | $298.97M |
| Neurogene Inc. (NGNE)vs › | $406.04M | $301.90M |
| Carlsmed, Inc. (CARL)vs › | $406.41M | $382.09M |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $407.34M | $331.21M |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | $398.93M |
| Strata Critical Medical, Inc. (SRTA)vs › | $409.70M | $397.64M |
| Rezolute, Inc. (RZLT)vs › | $409.72M | $400.04M |
| Prothena Corporation plc (PRTA)vs › | $411.33M | $130.13M |
| Myriad Genetics, Inc. (MYGN)vs › | $413.54M | $508.84M |
| MapLight Therapeutics, Inc. (MPLT)vs › | $391.80M | $322.15M |
Market Cap
$403.87M
Total Debt
$0.00
Cash
$104.90M
Enterprise Value
$298.97M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
